Aptus takes $30M to repair aneurysms
Aptus Endosystems, a biotech firm working on a device to fix abdominal aneurysms, just brought in $30 million in third-round funding to finish off clinical trials of its Abdominal Aortic Aneurysm Repair System, reports VentureWire. Heron Capital led the round, which also included Longitude Capital, Oakwood Medical Investors, Baird Venture Partners, FirstMark Capital, Prism VentureWorks and US Venture Partners.
The Sunnyvale, Calif. company says the round should be enough to cover the U.S. launch of the product in 2010 and a smaller release in Europe. Aptus last raised financing in 2006, bringing in $19.5 million to push the device through the first phases of trials.
Next Story: CES: Palm shows off its Palm Pre gesture-based smart phone
Previous Story: Roundup: Cuts at One Laptop Per Child, Yahoo takeover plans and more
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.